Actively Recruiting
Evaluation of the Impact of the AVanCer Program Provided by the ARRPAC Day Center
Led by Hospices Civils de Lyon · Updated on 2024-06-26
162
Participants Needed
1
Research Sites
147 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In France, more than 150,000 strokes occur each year. Stroke is a major risk factor for dependency, representing the leading cause of acquired non-traumatic disability in adults. Head injuries, which are also very frequent, can leave similar neuropsychiatric sequelae. These events are brutal and their physical, psychological, emotional, social and financial consequences disrupt the lives of patients and their families. Thanks to improved access to thrombolysis and thrombectomy for the management of acute stroke, the prognosis has been profoundly improved. Nevertheless, the increase in post-stroke survival and the evolution of the type of after-effects require the development of support systems dedicated to these post-stroke patients. The same issues are raised for people who have suffered a head injury with similar consequences that require specialised care. Currently, health care is well structured for the acute phase and there is an improvement in the provision of care in specialised rehabilitation services, but the dedicated medico-social provision for people returning home remains insufficient despite the significant needs. The ARRPAC association (Accompaniment, Rehabilitation, Respite after Stroke and Cerebral Palsy) is setting up a new comprehensive medico-social support programme in Lyon (AVanCer programme, opening in June 2022) to improve the autonomy and adaptation capacities of patients and to relieve the social and psycho-affective burden of carers. This experimental day centre, which complements functional rehabilitation and recurrence prevention care, offers adults with brain injury sequelae and their carers therapeutic education programmes, adapted physical activity, social and cognitive remediation and therapeutic workshops, as well as a place for patients and their carers to exchange information and listen. To achieve its ambition, ARRPAC and the AVanCer programme must be integrated into the existing support offer, create partnerships with care structures and evaluate its added value to ensure its sustainability. In case of efficiency and demonstrated benefits for patients, carers and the health system, such a structure could be deployed in other territories. This study evaluates the implementation of the AVanCer programme in terms of its effect on the target audience, participants' experience and implementation according to the REAIM evaluative framework (Reach, Effectiveness, Adoption, Implementation, and Maintenance).
CONDITIONS
Official Title
Evaluation of the Impact of the AVanCer Program Provided by the ARRPAC Day Center
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female of legal age
- Patient selected to start the AVanCer program at the ARRPAC center
- Patient who has agreed to participate in the assessment component and signed the consent form
- Patient able to speak and understand French both orally and in writing
- Caregiver of legal age
- Caregiver who has agreed to participate in the caregiving assessment and signed the consent form
- Caregiver able to speak and understand French both orally and in writing
- Voluntary patients and caregivers who participated in the quantitative part and follow-up questionnaires
- Partner professionals from ARRPAC referral partners during the first 12 months
- ARRPAC professionals involved in the day care center interviewed semi-structured
You will not qualify if you...
- Pregnant women, parturient or breastfeeding mothers
- Persons deprived of their liberty by judicial or administrative decision
- Persons under psychiatric care
- Persons admitted to health or social establishments for purposes other than research
- Persons of full age subject to legal protection measures (guardian, curator)
- Persons not affiliated with a social security scheme or similar beneficiary
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Accueil de jour ARRPAC
Bron, France, 69500
Actively Recruiting
Research Team
J
Julie Haesebaert, MD
CONTACT
A
Anne Termoz
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here